Earnings · China A-shares

Chengdu Easton Biopharmaceuticals Co., Ltd. Class A (688513) earnings

Chengdu Easton Biopharmaceuticals Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit -5.24% year on year, -4.56% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +0.61% in the 3 trading days after the report.

Report
Q3 report
Published
2026-10-27
Period end
2026-09-30
Net profit YoY
-5.24%
Excl. one-offs YoY
-4.56%
Net profit QoQ
-0.07%
Result
Neutral
Quality score
100
Quality
Sound
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day+2.72%—
3 days+0.61%—
7 days+3.85%—
14 days+2.79%—

Report history

Over the last 8 reports, net profit grew year on year in 3 of them. The stock rose in the 3 trading days after 3 of 6 reports (average -3.68%).

ReportPublishedNet profitProfit YoYExcl. one-offs YoYRevenue YoYEPSROE3 days after30 days after30d vs index
2026 Q3 report2026-10-28¥208.62M-5.24%-4.56%-2.81%1.206.97%+0.61%——
2026 interim report2026-08-21¥129.75M-4.99%-9.75%+0.68%0.744.33%-8.48%-3.97%+1.73%
2026 Q1 report2026-04-22¥50.83M-16.11%-17.81%+6.75%0.291.72%-3.10%-28.47%-30.06%
2025 annual report2026-04-22¥284.06M+19.24%+19.02%-1.36%1.6310.10%-3.10%-28.47%-30.06%
2025 Q3 report2025-10-28¥220.16M+1.45%+3.10%-2.00%1.257.93%+1.74%+4.69%+8.07%
2025 interim report2025-08-19¥136.57M-6.77%-8.68%-2.25%0.774.97%+1.21%-14.80%-23.97%
2025 Q1 report2025-04-25¥60.59M-19.22%-10.79%-2.97%0.342.22%-14.04%+13.11%+9.87%
2024 annual report2025-04-25¥238.23M+5.15%+10.90%+20.82%1.369.14%-14.04%+13.11%+9.87%

The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.

Stock valuations: 688513

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.